Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research Units
Equipment
Projects
Research output
Prizes
Activities
Press / Media
Search by expertise, name or affiliation
A Phase I study of MAX-40279 given orally to patients with acute myelogenous leukemia (AML)
Shortt, Jake
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Project Description
NMA HREC Reference Number: HREC/18/SVH/97
NMA SSA Reference Number: SSA/18/MonH/489
Monash Health Ref: RES-18-0000-385X
Status
Active
Effective start/end date
13/08/19
→
12/08/24
View all
View less
Keywords
clinical trial
phase 1 study
treatment efficacy
leukemia